hero-banner-text.svg

The Eversense PASS™ Program offers savings on THE ONLY long-term CGM System with 6 months of real-time glucose readings.

Payment Assistance and Simple Savings

To help eligible people with diabetes more affordably access the Eversense E3 CGM System†

 $99 for 6 months


Eligible individuals can experience EVERSENSE E3 CGM for only $99, now and in the future.†

That includes the patient’s initial and ongoing sensor and sensor/transmitter combinations – which is
equivalent to an average monthly cost of $16.50!

Eligibility Overview†


  • Eligibility: To be eligible, the patient must have a commercial insurance plan with or without coverage for the EVERSENSE® E3 CGM. The patient must also meet medical coverage criteria for CGM as indicated by their insurance provider.
  • Exclusions: Government insurance as primary or secondary coverage (i.e., Medicare, Medicare Advantage, Medicaid, and Tri-Care) or insurance plans that require purchase directly from HCPs (Health Care Professionals) via global payment.
Thanks! We've got your info.

A Diabetes Therapy Associate will be in touch shortly, but if you want to reach out sooner, please call 1-945-221-9068.

To help expedite benefits verification, please have your doctor and insurance information handy.

We will attempt to reach you by phone first, and will send a text and email as well. The call may be displayed on your phone as "Eversense CGM". However, it will come from a number you are unfamiliar with, so be sure to check your voicemail box. The email from our representative will come from an @ascensia.com email address. If you haven’t received any email communications from our team within a few days, please check the spam folder in your email account.

universal-scheduler-icon.png

You can also schedule your call with us at a date/time that is most convenient for you - just click here.

Looking forward to getting in touch with you!

Thanks! We've got your info.

Unfortunately, based on the insulin therapy regimen or insurance information you provided, you may not be eligible for Eversense E3 CGM. In order to qualify, you must be on multiple daily doses of insulin.

If your commercial insurance plan does not cover Eversense E3 CGM, our Eversense PASS™ program may help reduce your out-of-pocket cost for the product.

If you have any questions, please reach out to 1-844-736-7348.

A general error occurred. Please try again later.
Get Started with Eversense

If you're on insulin, you might greatly benefit from Eversense. After completing the form below, an Eversense representative will be in touch to discuss eligibility, coverage and next steps.

Please note: Eversense® E3 CGM is indicated for persons with diabetes age 18 and older.

Diabetes Type*
Number of Daily Insulin Injections*

By clicking ‘submit’ you confirm you are over 18, and agree to Ascensia, or our trusted partner, collecting and using your health-related information to check your insurance coverage and eligibility for Eversense. An Ascensia Diabetes Care representative will be in touch about getting started, usually by phone or text message.

HAVE YOU USED A CGM DEVICE BEFORE?
DO YOU CURRENTLY USE A BLOOD GLUCOSE METER?
PREFERRED LANGUAGE
PREFERRED METHOD OF COMMUNICATION

ON A SCALE OF 1 - 5, HOW READY ARE YOU TO GET STARTED?

† Offer does not apply to the insertion and removal procedures. The Eversense PASS Program has limitations on eligibility.
See website (bit.ly/EversensePass) for more details. Ascensia Diabetes Care reserves the right to change or terminate this program at any time without notice. The program benefit is capped per transaction. There may be instances in which out-of-pocket costs exceed what is detailed in the offer.

 

Disclaimer

The Eversense® E3 Continuous Glucose Monitoring (CGM) System is indicated for continually measuring glucose levels for up to 180 days in persons with diabetes age 18 and older. The system is indicated for use to replace fingerstick blood glucose (BG) measurements for diabetes treatment decisions. Fingerstick BG measurements are still required for calibration primarily one time a day after day 21, and when symptoms do not match CGM information or when taking medications of the tetracycline class. The sensor insertion and removal procedures are performed by a health care provider. The Eversense E3 CGM System is a prescription device; patients should talk to their health care provider to learn more.
For safety information click here.

Eversense, Eversense E3 Continuous Glucose Monitoring and the Eversense logo are trademarks of Senseonics, Incorporated. Ascensia, and the Ascensia Diabetes Care logo are trademarks and/or registered trademarks of Ascensia Diabetes Care Holdings AG. All other trademarks are properties of their respective owners and are used solely for informative purposes. No relationship or endorsement should be inferred or implied.

Apple Watch® is a product of Apple, Inc., and may be separately purchased from an authorized Apple retailer. Apple Watch is not included with the Eversense CGM System. Android is a trademark of Google LLC.

Get Started